1. Home
  2. ISOU vs ORGO Comparison

ISOU vs ORGO Comparison

Compare ISOU & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ISOU

IsoEnergy Ltd.

HOLD

Current Price

$10.61

Market Cap

501.4M

Sector

N/A

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.64

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISOU
ORGO
Founded
2016
1985
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
501.4M
348.6M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ISOU
ORGO
Price
$10.61
$2.64
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
80.0K
686.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
0.15
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.84
P/E Ratio
N/A
$17.67
Revenue Growth
N/A
17.04
52 Week Low
$5.94
$2.61
52 Week High
$13.58
$7.08

Technical Indicators

Market Signals
Indicator
ISOU
ORGO
Relative Strength Index (RSI) 45.87 23.16
Support Level $9.72 $2.61
Resistance Level $11.77 $5.08
Average True Range (ATR) 0.65 0.22
MACD -0.06 -0.05
Stochastic Oscillator 23.83 0.66

Price Performance

Historical Comparison
ISOU
ORGO

About ISOU IsoEnergy Ltd.

IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: